Share Facebook Twitter LinkedIn Pinterest Email Nektar Therapeutics chief R&D officer sells $57,692 in stock
Financial News Rollins stock gets Outperform rating from Bernstein on cost-cutting potentialNovember 17, 2025
By IsmailKhanBy IsmailKhan